The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years
- PMID: 29247151
- PMCID: PMC5880714
- DOI: 10.3899/jrheum.170806
The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years
Abstract
Objective: To examine the incidence of gout over the last 20 years and to evaluate possible changes in associated comorbid conditions.
Methods: The medical records were reviewed of all adults with a diagnosis of incident gout in Olmsted County, Minnesota, USA, during 2 time periods (January 1, 1989-December 31, 1992, and January 1, 2009-December 31, 2010). Incident cases had to fulfill at least 1 of 3 criteria: the American Rheumatism Association 1977 preliminary criteria for gout, the Rome criteria, or the New York criteria.
Results: A total of 158 patients with new-onset gout were identified during 1989-1992 and 271 patients during 2009-2010, yielding age- and sex-adjusted incidence rates of 66.6/100,000 (95% CI 55.9-77.4) in 1989-1992 and 136.7/100,000 (95% CI 120.4-153.1) in 2009-2010. The incidence rate ratio was 2.62 (95% CI 1.80-3.83). At the time of their first gout flare, patients diagnosed with gout in 2009-2010 had higher prevalence of comorbid conditions compared with 1989-1992, including hypertension (69% vs 54%), diabetes mellitus (25% vs 6%), renal disease (28% vs 11%), hyperlipidemia (61% vs 21%), and morbid obesity (body mass index ≥ 35 kg/m2; 29% vs 10%).
Conclusion: The incidence of gout has more than doubled over the recent 20 years. This increase together with the more frequent occurrence of comorbid conditions and cardiovascular risk factors represents a significant public health challenge.
Keywords: COMORBIDITY; EPIDEMIOLOGY; GOUT; INCIDENCE.
Figures
Comment in
-
A Changing Landscape of Gout: Comorbidity Matters.J Rheumatol. 2018 Apr;45(4):454-455. doi: 10.3899/jrheum.171446. J Rheumatol. 2018. PMID: 29606645 No abstract available.
Similar articles
-
The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.Semin Arthritis Rheum. 2017 Feb;46(4):451-456. doi: 10.1016/j.semarthrit.2016.08.006. Epub 2016 Aug 17. Semin Arthritis Rheum. 2017. PMID: 28040245 Free PMC article.
-
Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years.J Rheumatol. 2020 Apr;47(4):613-618. doi: 10.3899/jrheum.190346. Epub 2019 Jul 15. J Rheumatol. 2020. PMID: 31308206 Free PMC article.
-
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis.Adv Ther. 2016 Jul;33(7):1180-98. doi: 10.1007/s12325-016-0346-1. Epub 2016 May 26. Adv Ther. 2016. PMID: 27230988 Free PMC article.
-
Gout epidemiology and comorbidities.Semin Arthritis Rheum. 2020 Jun;50(3S):S11-S16. doi: 10.1016/j.semarthrit.2020.04.008. Semin Arthritis Rheum. 2020. PMID: 32620196 Review.
-
Epidemiology of gout: an update.Best Pract Res Clin Rheumatol. 2010 Dec;24(6):811-27. doi: 10.1016/j.berh.2010.10.004. Best Pract Res Clin Rheumatol. 2010. PMID: 21665128 Review.
Cited by
-
Oral Huzhang granules for the treatment of acute gouty arthritis: protocol for a double-blind, randomized, controlled trial.Trials. 2022 Apr 1;23(1):248. doi: 10.1186/s13063-022-06188-x. Trials. 2022. PMID: 35365187 Free PMC article.
-
Hospitalization Increases the Risk of Acute Arthritic Flares in Gout: A Population-based Study over 2 Decades.J Rheumatol. 2018 Aug;45(8):1188-1191. doi: 10.3899/jrheum.171320. Epub 2018 Jul 1. J Rheumatol. 2018. PMID: 29961683 Free PMC article.
-
The Impact of Natural Product Dietary Supplements on Patients with Gout: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evid Based Complement Alternat Med. 2020 Jan 23;2020:7976130. doi: 10.1155/2020/7976130. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32047527 Free PMC article. Review.
-
Progress in Treatment of Gout Using Chinese and Western Medicine.Chin J Integr Med. 2020 Jan;26(1):8-13. doi: 10.1007/s11655-019-3058-y. Epub 2019 Jan 18. Chin J Integr Med. 2020. PMID: 30659455
-
Construction and expression of recombinant uricase‑expressing genetically engineered bacteria and its application in rat model of hyperuricemia.Int J Mol Med. 2020 May;45(5):1488-1500. doi: 10.3892/ijmm.2020.4512. Epub 2020 Feb 24. Int J Mol Med. 2020. PMID: 32323736 Free PMC article.
References
-
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63:3136–41. - PubMed
-
- Portis AJ, Laliberte M, Tatman P, Moua M, Culhane-Pera K, Maalouf NM, et al. High prevalence of gouty arthritis among the Hmong population in Minnesota. Arthritis Care Res. 2010;62:1386–91. - PubMed
-
- Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29:2403–6. - PubMed
-
- Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31:1582–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical